MedDataX Logo

Femoral Block With or Without Ropivacaine for Analgesia After Total Knee Replacement (TKR)

NCT ID: NCT00910013

Last Updated: 2011-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-04-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Total knee replacement is a painful procedure. Many solutions have been proposed to diminish the post-operative doses of narcotics, including nerve blocks.

The purpose of the study is to compare if the adjunction of intra-articular ropivacaine to a femoral block is more effective on narcotics consumption than the block alone after TKR.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Knee Replacement

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

TKR Femoral block Ropivacaïne intra-articular ropivacaïne post-operative analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ropivacaine + femoral block

After the surgery is proceeded and after the closure of the joint capsule, 20 cc of ropivacaine 0.5% is inserted intra-articular through a catheter.

Group Type EXPERIMENTAL

Ropivacaine

Intervention Type DRUG

0.5% intra-articular ropivacaïne (20cc)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ropivacaine

0.5% intra-articular ropivacaïne (20cc)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary total knee replacement
* Age \> 18 years old
* Accept the study

Exclusion Criteria

* Revision surgery
* Use of anticoagulants drugs
* Neurologic disorder
* Unable to sign consent form
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital de l'Enfant-Jesus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Département orthopédie, CHA-Pavillon Enfant-Jésus

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr Stéphane Pelet, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

Hôpital Enfant-Jésus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHA-Pavillon Enfant-Jésus

Québec, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEJ-340

Identifier Type: -

Identifier Source: org_study_id